{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:03:59Z","timestamp":1791821039894,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702130"],"award-info":[{"award-number":["81702130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2019JQ-143"],"award-info":[{"award-number":["2019JQ-143"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteoporosis (OP) and osteoarthritis (OA) commonly coexist in postmenopausal females. The decrease in bone density and increase in bone resorption in postmenopausal females with OP may consequently affect the surgical outcome of total knee arthroplasty (TKA). However, clinicians often ignore monitoring the treatment of OP in the perioperative management of TKA. Bone turnover marker (BTM) can timely and accurately reflect bone metabolism to monitor the treatment of OP. The purpose of this study was to investigate the effect of BTM monitoring to guide the treatment of OP in postmenopausal females undergoing TKA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Postmenopausal females with OP who underwent primary unilateral TKA were randomly divided into two groups (monitoring group and control group), given oral medication (alendronate, calcitriol, and calcium), and followed for 1 year. In the monitoring group, serum BTMs (C-telopeptide of type I collagen (CTX-I), N-terminal propeptide of type I procollagen (PINP), and 25(OH)D) were assessed preoperatively and repeated postoperatively; alendronate was withdrawn when CTX-I and PINP reached the reference interval; and calcitriol and calcium were withdrawn when 25(OH)D reached the reference interval. In the control group, oral medication was implemented for a uniform duration of 3 months. During the 1-year follow-up, the mean maximum total point motion (MTPM) of the tibial component, bone mineral density (BMD), visual analog scale (VAS) score, range of motion, and Oxford Knee Score (OKS) score were obtained.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the monitoring group, BTM monitoring prolonged the medication duration, but did not cause more adverse reactions than in the control group. The mean MTPM values at 6 m and 12 m in the monitoring group were lower than those in the control group, and the BMD at 12 m in the monitoring group was significantly higher than that in the control group. Patients in the monitoring group had lower VAS scores at 6 m and higher OKS scores at 6 m and 12 m than those in the control group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In postmenopausal females with osteoporosis undergoing primary TKA, the application of BTM monitoring to guide the treatment of osteoporosis can enhance bone density, maintain prosthesis stability, and improve surgical outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ChiCTR <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=16986\">ChiCTR-INR-17010495<\/jats:ext-link>. Registered on 22 January 2017<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-021-02343-3","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T08:03:08Z","timestamp":1615968188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The use of bone turnover markers for monitoring the treatment of osteoporosis in postmenopausal females undergoing total knee arthroplasty: a prospective randomized study"],"prefix":"10.1186","volume":"16","author":[{"given":"Rui","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunzheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"issue":"5","key":"2343_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11926-013-0328-0","volume":"15","author":"IE Bultink","year":"2013","unstructured":"Bultink IE, Lems WF. Osteoarthritis and osteoporosis: what is the overlap? Curr Rheumatol Rep. 2013;15(5):328. https:\/\/doi.org\/10.1007\/s11926-013-0328-0.","journal-title":"Curr Rheumatol Rep."},{"key":"2343_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2018.01.019","volume":"110","author":"D Sharma","year":"2018","unstructured":"Sharma D, Larriera AI, Palacio-Mancheno PE, Gatti V, Fritton JC, Bromage TG, Cardoso L, Doty SB, Fritton SP. The effects of estrogen deficiency on cortical bone microporosity and mineralization. Bone. 2018;110:1\u201310. https:\/\/doi.org\/10.1016\/j.bone.2018.01.019.","journal-title":"Bone."},{"issue":"2","key":"2343_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jor.23003","volume":"34","author":"CC Huang","year":"2016","unstructured":"Huang CC, Jiang CC, Hsieh CH, Tsai CJ, Chiang H. Local bone quality affects the outcome of prosthetic total knee arthroplasty. J Orthop Res. 2016;34(2):240\u20138. https:\/\/doi.org\/10.1002\/jor.23003.","journal-title":"J Orthop Res."},{"issue":"9","key":"2343_CR4","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1002\/jbm.a.34972","volume":"102","author":"RD Valladares","year":"2014","unstructured":"Valladares RD, Nich C, Zwingenberger S, Li C, Swank KR, Gibon E, Rao AJ, Yao Z, Goodman SB. Toll-like receptors-2 and 4 are overexpressed in an experimental model of particle-induced osteolysis. J Biomed Mater Res A. 2014;102(9):3004\u201311. https:\/\/doi.org\/10.1002\/jbm.a.34972.","journal-title":"J Biomed Mater Res A."},{"key":"2343_CR5","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00198-019-05005-7","volume":"30","author":"D Briem","year":"2019","unstructured":"Briem D, Strametz S, Ks O, Nm M, Lehmann W, Linhart W, et al. Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis. Osteoporos Int. 2019;30:1581\u20139.","journal-title":"Osteoporos Int."},{"issue":"4","key":"2343_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1345\/aph.1E357","volume":"39","author":"AA Licata","year":"2005","unstructured":"Licata AA. Discovery, clinical development, and therapeutic uses of bisphosphonates. Ann Pharmacother. 2005;39(4):668\u201377. https:\/\/doi.org\/10.1345\/aph.1E357.","journal-title":"Ann Pharmacother."},{"issue":"4","key":"2343_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5435\/00124635-200604000-00003","volume":"14","author":"AS Shanbhag","year":"2006","unstructured":"Shanbhag AS. Use of bisphosphonates to improve the durability of total joint replacements. J AM Acad Orthop Sur. 2006;14(4):215\u201325. https:\/\/doi.org\/10.5435\/00124635-200604000-00003.","journal-title":"J AM Acad Orthop Sur."},{"key":"2343_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00198-015-3145-7","volume":"27","author":"KE Naylor","year":"2015","unstructured":"Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NFA, McCloskey EV, et al. Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int. 2015;27:21\u201331.","journal-title":"Osteoporos Int."},{"key":"2343_CR9","doi-asserted-by":"publisher","first-page":"S302","DOI":"10.1016\/j.jval.2018.09.1802","volume":"21","author":"F Fatoye","year":"2018","unstructured":"Fatoye F, Smith P, Gebrye T, Yeowell G. Real world persistence and adherence with oral bisphosphonates for osteoporosis - a systematic review. Value Health. 2018;21:S302\u2013S3. https:\/\/doi.org\/10.1016\/j.jval.2018.09.1802.","journal-title":"Value Health"},{"key":"2343_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00003086-199711000-00005","volume":"344","author":"AS Shanbhag","year":"1997","unstructured":"Shanbhag AS, Hasselman CT, Rubash HE. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop Relat Res. 1997;344:33\u201343.","journal-title":"Clin Orthop Relat Res."},{"issue":"6","key":"2343_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00223-002-1022-9","volume":"71","author":"TA Soininvaara","year":"2002","unstructured":"Soininvaara TA, Jurvelin JS, Miettinen HJ, Suomalainen OT, Alhava EM, Kroger PJ. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients. Calcif Tissue Int. 2002;71(6):472\u20137. https:\/\/doi.org\/10.1007\/s00223-002-1022-9.","journal-title":"Calcif Tissue Int."},{"issue":"2","key":"2343_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12020-016-0900-2","volume":"52","author":"SD Vasikaran","year":"2016","unstructured":"Vasikaran SD, Chubb SA. The use of biochemical markers of bone turnover in the clinical management of primary and secondary osteoporosis. Endocrine. 2016;52(2):222\u20135. https:\/\/doi.org\/10.1007\/s12020-016-0900-2.","journal-title":"Endocrine."},{"issue":"2","key":"2343_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1373\/clinchem.2016.259085","volume":"63","author":"MB Greenblatt","year":"2017","unstructured":"Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem. 2017;63(2):464\u201374. https:\/\/doi.org\/10.1373\/clinchem.2016.259085.","journal-title":"Clin Chem."},{"issue":"11","key":"2343_CR14","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S2213-8587(17)30184-5","volume":"5","author":"R Eastell","year":"2017","unstructured":"Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endo. 2017;5(11):908\u201323. https:\/\/doi.org\/10.1016\/S2213-8587(17)30184-5.","journal-title":"Lancet Diabetes Endo."},{"issue":"2","key":"2343_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00198-010-1501-1","volume":"22","author":"S Vasikaran","year":"2011","unstructured":"Vasikaran S, Eastell R, Bruyere O, Foldes AJ, Garnero P, Griesmacher A, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391\u2013420. https:\/\/doi.org\/10.1007\/s00198-010-1501-1.","journal-title":"Osteoporos Int."},{"issue":"4","key":"2343_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00198-018-04823-5","volume":"30","author":"KE Naylor","year":"2019","unstructured":"Naylor KE, McCloskey EV, Jacques RM, Peel NFA, Paggiosi MA, Gossiel F, et al. Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis. Osteoporos Int. 2019;30(4):917\u201322. https:\/\/doi.org\/10.1007\/s00198-018-04823-5.","journal-title":"Osteoporos Int."},{"key":"2343_CR17","unstructured":"WHO. WHO scientific group on the assessment of osteoporosis at primary health care level. Summary Meeting Report. 2004; Brussels."},{"issue":"4A","key":"2343_CR18","first-page":"1853","volume":"27","author":"D Pollmann","year":"2007","unstructured":"Pollmann D, Siepmann S, Geppert R, Wernecke KD, Possinger K, L\u00fcftner D. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Anticancer Res. 2007;27(4A):1853\u201362.","journal-title":"Anticancer Res."},{"issue":"4","key":"2343_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/17453670510041574","volume":"76","author":"ER Valstar","year":"2005","unstructured":"Valstar ER, Gill R, Ryd L, Flivik G, B\u00f6rlin N, K\u00e4rrholm J. Guidelines for standardization of radiostereometry (RSA) of implants. Acta Orthop. 2005;76(4):563\u201372. https:\/\/doi.org\/10.1080\/17453670510041574.","journal-title":"Acta Orthop."},{"key":"2343_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0883-5403(99)90196-1","volume":"14","author":"KG Nilsson","year":"1999","unstructured":"Nilsson KG, Kirrholm J, Carlsson L, Dal\u00e9n T. Hydroxyapatite coating versus cemented fixation of the tibial component in total knee arthroplasty. Prospective randomized comparison of hydroxyapatite-coated and cemented tibial components with 5-year follow-up using radiostereometry (RSA). J Arthroplasty. 1999;14:9\u201320.","journal-title":"J Arthroplasty"},{"issue":"10","key":"2343_CR21","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1016\/j.arth.2019.05.019","volume":"34","author":"KN Linde","year":"2019","unstructured":"Linde KN, Madsen F, Puhakka KB, Langdahl BL, Soballe K, Krog-Mikkelsen I, et al. Preoperative systemic bone quality does not affect tibial component migration in knee arthroplasty: A 2-year radiostereometric analysis of a hundred consecutive patients. J Arthroplasty. 2019;34(10):2351\u20139. https:\/\/doi.org\/10.1016\/j.arth.2019.05.019.","journal-title":"J Arthroplasty."},{"key":"2343_CR22","first-page":"1","volume":"220","author":"L Ryd","year":"1986","unstructured":"Ryd L. Micromotion in Knee Arthroplasty. A roentgen stereophotogrammetric analysis of tibial component fixation. Acta Orthop Scand Suppl. 1986;220:1\u201380.","journal-title":"Acta Orthop Scand Suppl."},{"issue":"982","key":"2343_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/pgmj.2007.057505","volume":"83","author":"GM Blake","year":"2007","unstructured":"Blake GM, Fogelman I. The role of DXA bone density scans in the diagnosis and treatment of osteoporosis. Postgrad Med J. 2007;83(982):509\u201317. https:\/\/doi.org\/10.1136\/pgmj.2007.057505.","journal-title":"Postgrad Med J."},{"issue":"Suppl 1","key":"2343_CR24","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1097\/BOT.0b013e3181ca3fbd","volume":"24","author":"BW Kooistra","year":"2010","unstructured":"Kooistra BW, Sprague S, Bhandari M, Schemitsch EH. Outcomes assessment in fracture healing trials: A primer. J Orthop Trauma. 2010;24(Suppl 1):S71\u20135. https:\/\/doi.org\/10.1097\/BOT.0b013e3181ca3fbd.","journal-title":"J Orthop Trauma."},{"issue":"2","key":"2343_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/art.1780230203","volume":"23","author":"R Meenan","year":"1980","unstructured":"Meenan R, Gertman P, Mason J. Measuring heaIth status in arthritis: the arthritis impact measurement scales. Arthritis Rheum. 1980;23(2):146\u201352. https:\/\/doi.org\/10.1002\/art.1780230203.","journal-title":"Arthritis Rheum."},{"issue":"2","key":"2343_CR26","first-page":"208","volume":"18","author":"S Rizou","year":"2018","unstructured":"Rizou S, Chronopoulos E, Ballas M, Lyritis GP. Clinical manifestations of osteoarthritis in osteoporotic and osteopenic postmenopausal women. J Musculoskelet Neuronal Interact. 2018;18(2):208\u201314.","journal-title":"J Musculoskelet Neuronal Interact."},{"key":"2343_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.bone.2018.03.016","volume":"111","author":"F Gossiel","year":"2018","unstructured":"Gossiel F, Altaher H, Reid DM, Roux C, Felsenberg D, Gl\u00fcer C-C, Eastell R. Bone turnover markers after the menopause: T-score approach. Bone. 2018;111:44\u20138. https:\/\/doi.org\/10.1016\/j.bone.2018.03.016.","journal-title":"Bone."},{"issue":"6","key":"2343_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/MED.0000000000000446","volume":"25","author":"S Jain","year":"2018","unstructured":"Jain S, Camacho P. Use of bone turnover markers in the management of osteoporosis. Curr Opin Endocrinol Diabetes Obes. 2018;25(6):366\u201372. https:\/\/doi.org\/10.1097\/MED.0000000000000446.","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"2","key":"2343_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1359\/JBMR.041114","volume":"20","author":"BL Riggs","year":"2005","unstructured":"Riggs BL, Parfitt AM. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res. 2005;20(2):177\u201384. https:\/\/doi.org\/10.1359\/JBMR.041114.","journal-title":"J Bone Miner Res."},{"key":"2343_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00198-012-1925-x","volume":"24","author":"JK Lee","year":"2012","unstructured":"Lee JK, Lee CH, Choi CH. QCT bone mineral density responses to 1 year of oral bisphosphonate after total knee replacement for knee osteoarthritis. Osteoporosis Int. 2012;24:287\u201392.","journal-title":"Osteoporosis Int."},{"issue":"11","key":"2343_CR31","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1359\/jbmr.07090b","volume":"22","author":"R Eastell","year":"2007","unstructured":"Eastell R, Hannon RA, Garnero P, Campbell MJ, Delmas PD. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate: review of statistical analysis. J Bone Miner Res. 2007;22(11):1656\u201360. https:\/\/doi.org\/10.1359\/jbmr.07090b.","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2343_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/17453674.2012.678798","volume":"83","author":"HT Aro","year":"2012","unstructured":"Aro HT, Alm JJ, Moritz N, M\u00e4kinen TJ, Lankinen P. Low BMD affects initial stability and delays stem osseointegration in cementless total hip arthroplasty in women. Acta Orthop. 2012;83(2):107\u201314. https:\/\/doi.org\/10.3109\/17453674.2012.678798.","journal-title":"Acta Orthop."},{"issue":"1","key":"2343_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/17453674.2015.1115312","volume":"87","author":"S Finnila","year":"2016","unstructured":"Finnila S, Moritz N, Svedstro ME, Alm JJ, Aro HT. Increased migration of uncemented acetabular cups in female total hip arthroplasty patients with low systemic bone mineral density. A 2-year RSA and 8-year radiographic follow-up study of 34 patients. Acta Orthop. 2016;87(1):48\u201354. https:\/\/doi.org\/10.3109\/17453674.2015.1115312.","journal-title":"Acta Orthop."},{"issue":"2","key":"2343_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11420-018-9614-8","volume":"14","author":"CA Kahlenberg","year":"2018","unstructured":"Kahlenberg CA, Nwachukwu BU, McLawhorn AS, Cross MB, Cornell CN, Padgett DE. Patient satisfaction after total knee replacement: A systematic review. HSSJ. 2018;14(2):192\u2013201. https:\/\/doi.org\/10.1007\/s11420-018-9614-8.","journal-title":"HSSJ."},{"issue":"1","key":"2343_CR35","first-page":"50","volume":"9","author":"M Muratore","year":"2012","unstructured":"Muratore M, Quarta E, Quarta L, Calcagnile F, Grimaldi A, Orgiani MA, Marsilio A, Rollo G. Ibandronate and cementless total hip arthroplasty: densitometric measurement of periprosthetic bone mass and new therapeutic approach to the prevention of aseptic loosening. Clin Cases Miner Bone Metab. 2012;9(1):50\u20135.","journal-title":"Clin Cases Miner Bone Metab."}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13018-021-02343-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T08:06:41Z","timestamp":1615968401000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-021-02343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1186\/s13018-021-02343-3","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"14 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Xi\u2019an Jiaotong University. All participants gave written informed consent and agreed for the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}